YieldMax MRNA Option Income Strategy ETF

MRNY

Market cap $133M

YieldMax MRNA Option Income Strategy ETF offers a high-yield, high-risk profile, best used for tactical income generation rather than long-term holding. MRNY's 105%+ yield is driven by an aggressive option-writing strategy, but NAV erosion is inevitable due to capped upside and full downside exposure. Total returns are highly dependent on timing; MRNY underperforms MRNA in strong rallies and fails to buffer sharp drawdowns effectively.

CHICAGO and MILWAUKEE and NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex.

CHICAGO and MILWAUKEE and NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex.

CHICAGO and MILWAUKEE and NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex.

CHICAGO and MILWAUKEE and NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs.

CHICAGO and MILWAUKEE and NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex.

CHICAGO and MILWAUKEE and NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex.

CHICAGO and MILWAUKEE and NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs.

YieldMax MRNA Option Income Strategy ETF (MRNY) is maintained as a Sell due to heightened downside risk and overvalued pipeline optimism. MRNY's aggressive 100% covered call strategy captures some upside but offers limited downside protection and lower income in flat markets. Moderna's (MRNA) revenue base is structurally declining, with oncology pipeline progress already priced into an elevated EV/revenue multiple.

CHICAGO and MILWAUKEE and NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex.